Table 2. Sensitivity and specificity analysis in validation study of self-reported type 2 diabetes in Shanghai (n = 4,322).
FPG values ≥7.0 mmol/L or use of diabetes medication (n = 4,322) |
|||
Yes | No | Total | |
Self-reported diabetes | |||
Yes | 578 | 30 | 608 |
No | 225 | 3,489 | 3,714 |
Total | 803 | 3,519 | 4,322 |
Validation measurements | |||
Sensitivity, % (95% CI) | 72.0 (68.7–75.1) | ||
Specificity, % (95% CI) | 99.2 (98.8–99.4) | ||
PPV, % (95% CI) | 95.1 (93.0–96.7) | ||
NPV, % (95% CI) | 93.9 (93.1–94.7) | ||
Kappa (95% CI) | 0.78 (0.76–0.81) |
CI, confidence interval; FPG, fasting plasma glucose; NPV, negative predictive value; PPV, positive predictive value.
Data for sensitivity, specificity, PPV and NPV are shown as percentages (95% confidence intervals).
Data for Kappa is shown as Kappa value (95% confidence interval).